Franklin Biotechnology Disc A Acc $

Performance History28/02/2015
Growth of 1,000 (EUR)
Franklin Biotechnology Disc A Acc $
Fund13.324.957.253.419.8
+/-Cat11.40.26.04.90.6
+/-Idx-5.6-16.9-3.34.53.2
 
Key Stats
NAV
27/03/2015
 USD 35.80
Day Change 1.85%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
27/02/2015
 USD 2865.49
Share Class Size (Mil)
28/02/2015
 USD 2306.08
Max Initial Charge 5.75%
Ongoing Charge
16/01/2015
  1.81%
Investment Objective: Franklin Biotechnology Disc A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns27/03/2015
YTD26.68
3 Years Annualised49.94
5 Years Annualised35.62
10 Years Annualised19.75
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Jerel Banks
01/09/2012
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Disc A Acc $31/10/2014
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks97.670.0097.67
Bonds0.000.000.00
Cash2.340.002.33
Other0.000.000.00
Top 5 Regions%
United States95.50
United Kingdom2.78
Eurozone0.95
Canada0.60
Europe - ex Euro0.16
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare10.06
Gilead Sciences IncHealthcareHealthcare8.32
Biogen Idec IncHealthcareHealthcare6.71
Amgen IncHealthcareHealthcare5.53
Medivation IncHealthcareHealthcare3.80
Franklin Biotechnology Disc A Acc $